Correlation between prognostic markers and clinical parameters in hepatocellular carcinoma: Pathophysiological aspects to therapeutic targets
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Identifying novel prognostic markers like MEX3A and Glypican-3 is crucial for improving outcomes in hepatocellular carcinoma (HCC) patients. These biomarkers aid in assessing prognosis and guiding targeted therapies for this common cancer.
Area Of Science
- Hepatology and Oncology
- Cancer Biomarkers
Background
- Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality worldwide.
- Despite advances in treatment, patient prognosis for HCC is often poor.
- Accurate prognostic indicators are vital for patient management and predicting outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...